The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation

Biomaterials

Volumn 31, Issue 6, 2010, Pages 1242-1250

  Kanczler, Janos M ^a   Ginty, Patrick J ^b   White, Lisa ^b   Clarke, Nicholas M P ^c   Howdle, Steven M ^b   Shakesheff, Kevin M ^b   Oreffo, Richard O C ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

BMP 2; Bone tissue regeneration; Critical sized femur defect; Human bone marrow stromal cells; Supercritical CO2; VEGF

Indexed keywords

BIODEGRADABLE SCAFFOLD; BMP-2; BONE DEFECT; BONE FORMATION; BONE MATRIX; BONE MORPHOGENIC PROTEIN; BONE TISSUE; BONE TISSUE REGENERATION; COMPOSITE SCAFFOLDS; DEFECT STUDY; HISTOLOGICAL EXAMINATION; HUMAN BONE MARROW STROMAL CELLS; HUMAN BONE MARROW STROMAL CELLS (HBMSC); MIXING TECHNIQUES; OSTEOGENIC; OSTEOPROGENITOR CELLS; SIGNAL CASCADES; SUPERCRITICAL CO; VASCULAR ENDOTHELIAL GROWTH FACTOR;

ALGINATE; BIOACTIVITY; CELL CULTURE; CELL PROLIFERATION; COORDINATION REACTIONS; DEFECTS; FLUORINE CONTAINING POLYMERS; PEPTIDES; SCAFFOLDS; SELF ASSEMBLY;

BONE;

ALGINIC ACID; BONE MORPHOGENETIC PROTEIN 2; CARBON DIOXIDE; POLYLACTIC ACID; VASCULOTROPIN 165;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIODEGRADABILITY; BONE DEFECT; BONE REGENERATION; BONE REMODELING; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; ENCAPSULATION; ENCHONDRAL OSSIFICATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUPERCRITICAL FLUID;

ADULT; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELLS, CULTURED; DRUG COMBINATIONS; FEMORAL FRACTURES; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; OSTEOBLASTS; OSTEOGENESIS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 72449179318     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.10.059     Document Type: Article

References (47)

1. Langer R., and Vacanti J.P. Tissue engineering. Science 260 (1993) 920-926
2. Bolland B.J., Tilley S., New A.M., Dunlop D.G., and Oreffo R.O. Adult mesenchymal stem cells and impaction grafting: a new clinical paradigm shift. Expet Rev Med Dev 4 (2007) 393-404
3. Kneser U., Schaefer D.J., Polykandriotis E., and Horch R.E. Tissue engineering of bone: the reconstructive surgeon's point of view. J Cell Mol Med 10 (2006) 7-19
4. Murphy W.L., Simmons C.A., Kaigler D., and Mooney D.J. Bone regeneration via a mineral substrate and induced angiogenesis. J Dent Res 83 (2004) 204-210
5. Levenberg S., Rouwkema J., Macdonald M., Garfein E.S., Kohane D.S., Darland D.C., et al. Engineering vascularized skeletal muscle tissue. Nat Biotechnol 23 (2005) 879-884
6. Yang X.B., Whitaker M.J., Sebald W., Clarke N., Howdle S.M., Shakesheff K.M., et al. Human osteoprogenitor bone formation using encapsulated bone morphogenetic protein 2 in porous polymer scaffolds. Tissue Eng 10 (2004) 1037-1045
7. Huang Y.C., Kaigler D., Rice K.G., Krebsbach P.H., and Mooney D.J. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res 20 (2005) 848-857
8. Kaigler D., Wang Z., Horger K., Mooney D.J., and Krebsbach P.H. VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. J Bone Miner Res 21 (2006) 735-744
9. Putnam A.J., and Mooney D.J. Tissue engineering using synthetic extracellular matrices. Nat Med 2 (1996) 824-826
10. Richardson T.P., Peters M.C., Ennett A.B., and Mooney D.J. Polymeric system for dual growth factor delivery. Nat Biotechnol 19 (2001) 1029-1034
11. Brey E.M., King T.W., Johnston C., McIntire L.V., Reece G.P., and Patrick Jr. C.W. A technique for quantitative three-dimensional analysis of microvascular structure. Microvasc Res 63 (2002) 279-294
12. Carano R.A., and Filvaroff E.H. Angiogenesis and bone repair. Drug Discov Today 8 (2003) 980-9889
13. Gerber H.P., Vu T.H., Ryan A.M., Kowalski J., Werb Z., and Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5 (1999) 623-628
14. Mayr-Wohlfart U., Waltenberger J., Hausser H., Kessler S., Gunther K.P., Dehio C., et al. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 30 (2002) 472-477
15. Wang Y., Wan C., Deng L., Liu X., Cao X., Gilbert S.R., et al. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 117 (2007) 1616-1626
16. Bouletreau P.J., Warren S.M., Spector J.A., Peled Z.M., Gerrets R.P., Greenwald J.A., et al. Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: implications for fracture healing. Plast Reconstr Surg 109 (2002) 2384-2397
17. Deckers M.M., van Bezooijen R.L., van der Horst G., Hoogendam J., van Der Bent C., Papapoulos S.E., et al. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 143 (2002) 1545-1553
18. Hausman M.R., Schaffler M.B., and Majeska R.J. Prevention of fracture healing in rats by an inhibitor of angiogenesis. Bone 29 (2001) 560-564
19. Street J., Bao M., deGuzman L., Bunting S., Peale Jr. F.V., Ferrara N., et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A 99 (2002) 9656-9661
20. Kanczler J.M., Ginty P.J., Barry J.J., Clarke N.M., Howdle S.M., Shakesheff K.M., et al. The effect of mesenchymal populations and vascular endothelial growth factor delivered from biodegradable polymer scaffolds on bone formation. Biomaterials 29 (2008) 1892-1900
21. Simmons C.A., Alsberg E., Hsiong S., Kim W.J., and Mooney D.J. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 35 (2004) 562-569
22. Ginty P.J., Barry J.J., White L.J., Howdle S.M., and Shakesheff K.M. Controlling protein release from scaffolds using polymer blends and composites. Eur J Pharm Biopharm 68 (2008) 82-89
23. Oreffo R.O., Virdi A.S., and Triffitt J.T. Modulation of osteogenesis and adipogenesis by human serum in human bone marrow cultures. Eur J Cell Biol 74 (1997) 251-261
24. Jaffe E.A., Nachman R.L., Becker C.G., and Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52 (1973) 2745-2756
25. Sojo K., Sawaki Y., Hattori H., Mizutani H., and Ueda M. Immunohistochemical study of vascular endothelial growth factor (VEGF) and bone morphogenetic protein-2, -4 (BMP-2, -4) on lengthened rat femurs. J Craniomaxillofac Surg 33 (2005) 238-245
26. Weiss S., Zimmermann G., Pufe T., Varoga D., and Henle P. The systemic angiogenic response during bone healing. Arch Orthop Trauma Surg 129 (2009) 989-997
27. Howdle S.M., Watson M.S., Whitaker M.J., Popov V.K., Davies M.C., Mandel F.S., et al. Supercritical fluid mixing: preparation of thermally sensitive polymer composites containing bioactive materials. Chem Commun 01 (2001) 109-110
28. Hou L.T., Liu C.M., Liu B.Y., Chang P.C., Chen M.H., Ho M.H., et al. Tissue engineering bone formation in novel recombinant human bone morphogenic protein 2-atelocollagen composite scaffolds. J Periodontol 78 (2007) 335-343
29. Bancroft J.D. Enzyme histochemistry and its diagnostic applications. In: Bancroft J.D., and Gamble M. (Eds). Theory and practise of histological techniques (2002), Churchill Livingstone Press, London 596-598
30. Miao D., and Scutt A. Histochemical localization of alkaline phosphatase activity in decalcified bone and cartilage. J Histochem Cytochem 50 (2002) 333-340
31. Kanczler J.M., Barry J., Ginty P., Howdle S.M., Shakesheff K.M., and Oreffo R.O. Supercritical carbon dioxide generated vascular endothelial growth factor encapsulated poly(DL-lactic acid) scaffolds induce angiogenesis in vitro. Biochem Biophys Res Commun 352 (2007) 135-141
32. Uchida S., Sakai A., Kudo H., Otomo H., Watanuki M., Tanaka M., et al. Vascular endothelial growth factor is expressed along with its receptors during the healing process of bone and bone marrow after drill-hole injury in rats. Bone 32 (2003) 491-501
33. Kanczler J.M., and Oreffo R.O. Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 15 (2008) 100-114
34. Kaigler D., Krebsbach P.H., Polverini P.J., and Mooney D.J. Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells. Tissue Eng 9 (2003) 95-103
35. Wan C., Gilbert S.R., Wang Y., Cao X., Shen X., Ramaswamy G., et al. Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proc Natl Acad Sci U S A 105 (2008) 686-691
36. Guillotin B., Bareille R., Bourget C., Bordenave L., and Amédée J. Interaction between human umbilical vein endothelial cells and human osteoprogenitors triggers pleiotropic effect that may support osteoblastic function. Bone 42 (2008) 1080-1091
37. Ferrari G., Pintucci G., Seghezzi G., Hyman K., Galloway A.C., and Mignatti P. V. a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis. Proc Natl Acad Sci 103 (2006) 17260-17265
38. Saito N., Okada T., Horiuchi H., Ota H., Takahashi J., Murakami N., et al. Local bone formation by injection of recombinant human bone morphogenetic protein-2 contained in polymer carriers. Bone 32 (2003) 381-386
39. Bessho K., Carnes D.L., Cavin R., and Ong J.L. Experimental studies on bone induction using low-molecular-weight poly (DL-lactide-co-glycolide) as a carrier for recombinant human bone morphogenetic protein- 2. J Biomed Mater Res 61 (2002) 61-65
40. Wei G., Jin Q., Giannobile W.V., and Ma P.X. The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres. Biomaterials 28 (2007) 2087-2096
41. Geiger F., Bertram H., Berger I., Lorenz H., Wall O., Eckhardt C., et al. Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J Bone Miner Res 20 (2005) 2028-2035
42. Peng H., Usas A., Olshanski A., Ho A.M., Gearhart B., Cooper G.M., et al. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 20 (2005) 2017-2027
43. Oest M.E., Dupont K.M., Kong H.J., Mooney D.J., and Guldberg R.E. Quantitative assessment of scaffold and growth factor-mediated repair of critically sized bone defects. J Orthop Res 25 (2007) 941-950
44. Patel Z.S., Young S., Tabat Y., Jansen J.A., Wong M.E., and Mikos A.G. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical sized defect model. Bone 43 (2008) 931-940
45. Kempen D.H., Lu L., Heijink A., Hefferan T.E., Creemers L.B., Maran A., et al. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 30 (2009) 2816-2825
46. Kaigler D., Krebsbach P.H., West E.R., Horger K., Huang Y.C., and Mooney D.J. Endothel cell modulation bone marrow stromal cell osteogenic potential. FASEB J 19 (2005) 665-667
47. Yu H., Vandevord P.J., Gong W., Wu B., Song Z., Matthew H.W., et al. Promotion of osteogenesis in tissue-engineered bone by pre-seeding endothelial progenitor cells-derived endothelial cells. J Orthop Res 26 (2008) 1147-1152